NeuroFlow

NeuroFlow operates at the intersection of behavioral health software, population health, care coordination, and healthcare analytics. Its platform serves payers, health systems, providers, and government or military programs rather than focusing exclusively on direct-to-consumer mental wellness. That broad buyer base is reflected in products such as IntegrateBH, BHIQ, TxProgress, Onward by NeuroFlow, and referral-management tools. The company’s differentiation is the combination of risk stratification, automated assessments, patient engagement, referral navigation, care-team workflows, and longitudinal outcome tracking in one behavioral-health environment. BHIQ extends the proposition toward payer and provider performance management by combining claims, EHR, ADT, and assessment data. IntegrateBH addresses enterprise integration across the care continuum, while TxProgress supports measurement-informed care and treatment tracking. The available comparable-company list does not identify distinct named competitors, so a precise peer ranking is not possible. NeuroFlow’s competitive position is nevertheless more enterprise-oriented than a standalone wellness application and more operationally integrated than a narrow assessment or referral product. Its $60.6 million reported funding total and 101–250 employee range indicate a scaled growth-stage healthcare software business, while the 2023–2025 acquisitions suggest an effort to broaden platform capabilities.

NeuroFlow’s financing history shows a progression from a $1.25 million seed round in 2017 and a $2.28 million seed round in 2018 to a $7.5 million Series A in 2019, a $20 million Series B in 2021, and a $25 million Series C in 2022. Grants, including a $2.5 million award in 2025, supplement the equity financing and support the company’s research and public-sector orientation. The clearest strategic inflection point was the shift from a core digital behavioral-health engagement platform toward a broader enterprise infrastructure layer. IntegrateBH combines population analytics, assessments, referrals, engagement, and outcome tracking, while BHIQ, launched on Jun 10, 2025, adds behavioral-health intelligence for payer and provider risk management. NeuroFlow also expanded through acquisitions in 2023, 2024, and 2025, including Capital Solution Design, Owl Insights, and Quartet Health.